Platelet MAO and personality - Function and dysfunction

Current Medicinal Chemistry

Volumn 11, Issue 15, 2004, Pages 2007-2016

  Oreland, Lars ^a   Hallman, J ^a   Damberg, M ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Alcoholism; AP 2; Mitochondria; Monoamine systems; Personality; Platelet monoamine oxidase; Serotonin; Transcription factors

Indexed keywords

1,2,3,4 TETRAHYDROQUINOLINE DERIVATIVE; 2 NAPHTHYLAMINE; AMINE OXIDASE (FLAVIN CONTAINING); AMINO ACID DECARBOXYLASE; BENZOQUINONE DERIVATIVE; BIOLOGICAL MARKER; CHOLINE ACETYLTRANSFERASE; CIGARETTE SMOKE; DOPAMINE 1 RECEPTOR; DOPAMINE BETA MONOOXYGENASE; DOPAMINE TRANSPORTER; MONOAMINE OXIDASE INHIBITOR; SEROTONIN TRANSPORTER; THROMBOCYTE ENZYME; TRANSCRIPTION FACTOR AP 2; TRYPTOPHAN HYDROXYLASE;

ALCOHOLISM; ANXIETY DISORDER; BEHAVIOR DISORDER; CIGARETTE SMOKING; ENZYME ACTIVITY; ENZYME INHIBITION; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION; HUMAN; IMPULSIVENESS; IRRITABILITY; MONOAMINERGIC SYSTEM; MOOD DISORDER; PERSONALITY DISORDER; PROTEIN FUNCTION; RETROSPECTIVE STUDY; REVIEW; SCHIZOPHRENIA; SENSATION; SUBSTANCE ABUSE;

EID: 3242769927     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/0929867043364838     Document Type: Review

References (164)

1. Shih, J.C.; Chen, K. Neurobiol., 1999.
2. Brunner, H.G.; Nelen, M.; Breakfield, X.O.; Ropers, H.H; van Oost, B.A. Science, 1993, 262, 578.
3. Shih, J.C.; Thompson, R.F. Am. J. Hum. Genet., 1999, 65, 593.
4. Garpenstrand, H.; Ekblom, J.; Forslund, K.; Rylander, G.; Oreland, L. J. Neural. Transm., 2000, 107, 523.
5. Holschneider, D.P.; Chen, K.; Seif, I.; Shih, J.C. Brain Res. Bull., 2001, 56, 453.
6. Oreland, L.; Arai, Y.; Stenström, A.; Fowler, C.J.: Monoamine oxidase activity and localization in the brain and the activity in relation to psychiatric disorders. In: "MAO in Psychiatric Research". Mod. Probl. Pharmacolpsychiat., Karger, Basel, 1983, 19, 246.
7. Fowler, C.J.; Wiberg, Å.; Oreland, L.; Marcusson, J.; Winblad, B. J. Neural. Transm., 1980, 49, 1.
8. Winblad, B.; Gottfries, C.-G.; Oreland, L.; Wiberg, Å.; Medical Biology, 1979, 57, 129.
9. Pletscher, A.; Bernstein, A. Nature, 1958, 181, 1133.
10. Paasonen, M. K. Biochem. Pharmacol., 1961, 8, 241.
11. Paasonen, M.K.; Solatunturi, E.; Kivalo, E. Psychopharmacologia. 1964, 6, 120.
12. Collins, G.G.S.M, Sandler, M. Biochem. Pharmacol., 1971, 20, 289.
13. Murphy, D.L.; Donnelly, C.H. Monoamine oxidase in man: enzyme characteristics in platelets, plasma and other human tissues. In Neuropsychopharmacology of Monoamines and their Regulatory Enzymes (Usdin E ed.). Raven Press NY, 1974, pp 71-85.
14. Garrick, N.A.; Redmond, D.E.; Murphy, D.L. Primate-rodent monoamine oxidase differences. In: Monoamine Oxidase: Structure, function, and Altered Functions. Eds. Singer TP, von Korff RW, Murphy DL. Academic Press NY, 1979, p351-359.
15. Chen, K.; Wu, H.F.; Shih, J.C. J. Neurochem., 1993, 61, 187.
16. Fowler, C.J.; Ekstedt, B.; Egashira, T.; Kinemuchi, H.; Oreland, L. Biochem. Pharmacol., 1979 28, 3063.
17. Robinson, D.S.; Davis, J.M.; Nies, A.; Colburn, R.W.; Davis, J.N.; Bourne, H.R.; Bunney, W.E.; Shaw, D.M.; Coppen, A.J. Lancet, 1972, 1, 290.
18. Murphy, D.L. Clinical, genetic, hormonal and drug influences on the activity of human platelet monoamine oxidase. In: Monoamine oxidase and its inhibition. Ciba Foundation Symposium, 1976, 39. 341-351. Elsevier, Amsterdam.
19. Bridge, T.P.; Soldo, B.J.; Phelps, B.H.; Wise, C.D.; Franacak, M.J.; Wyatt, R.J. J. Gerontol., 1985, 40, 23.
20. Bagdy, G.; Rihmer, Z. Acta Physiol. Hung., 1986, 68, 19.
21. Nies, A.; Robinson, D.S.; Lamborn, K.R.; Lampert, R.P.; Arch Gen. Psychiatry, 1973, 28, 834.
22. Oxenstierna, G.; Edman, G.; Iselius, L.; Oreland, L.; Ross, S.; Sedvall, G. J. Psychiat. Re.s, 1986, 20, 19.
23. Pedersen, N.L.; Oreland, L.; Reynolds, C.; McClearn, G.E. Psychiat. Res., 1993, 6, 239.
24. Latt, N.; Rippey, J.J.; Stacey, R.S. Br. Pharmacol. and Chemother., 1968, 32, 427.
25. Regland, B.; Gottfries, C.G.; Oreland, L. Eur. Arch. Psych. Clin. Neurosci., 1991, 240, 288.
26. Adolfsson, R.; Gottfries, C.G.; Oreland, L.; Wiberg, A.; Winblad B. Life Sci., 1980, 22, 1029.
27. Oreland, L.; Gottfries, C.G. Progr Neuro-Psycho-Pharmacol & Biol. Psychiatry, 1986b, 10, 533.
28. Soto, J.; Ulibarri, I.; Jauregui, J.V.; Ballesteros, J.; Meana, J.J. J. Psychiat. Res., 1999, 33, 251.
29. Jarman, J.; Glover, V.; Sandler, M.; Turjanski, N.; Stern, G. J. Neural. Trasm. Park. Dis. Dement. Sect., 1993, 5, 1.
30. Bongioanni, P.; Mondino, C.; Boccardi, B.; Borgna, M.; Castagna, M. Neurodegeneration, 1996, 5, 351.
31. Mann, J.; Chiu, E. J. Neurol. Neurosurg. Psychiatry, 1978, 41, 809.
32. Norman, T.R.; Chiu, E.; French, M.A. Clin. Exp. Pharmacol. Physiol., 1987, 14, 547.
33. Huang and Bowden, 1984.
34. Sofuoglu, S.; Dogan, P.; Kose, K.; Esel, E.; Basturk, M.; Oguz, H.; Gonul, A.S. Psychiat. Res., 1995, 29, 165.
35. Knoll, J.; Magyar, K. Some puzzling pharmacological effects of monoamine oxidase inhibitors. In Monoamine Oxidases - New vistas (Costa E, Sandler M, eds.) (Adv Biochem Psychopharmacol 5). Raven Press, Nyand North-Holland, Amsterdam. 1972, pp. 393-408.
36. Tipton, K.F. Clin. Pharmacol. Ther., 1994, 56, 781.
37. Murphy, D.L.; Wyatt, R.J. Nature, 1972, 238, 225.
38. Buchsbaum, M.S.; Coursey, R.D.; Murphy, D.L. Science, 1976, 194, 339.
39. Gottfries, C-G; Oreland, L.; Wiberg, Å.; Winblad, B. J. Neurochem., 1975, 25, 67.
40. Arai, Y.; Stenström, A; Oreland, L. Biogenic Amines, 1985, 2, 65.
41. Levitt, P.; Pintar, J.E.; Breakefield, X.O. Proc. Natl. Acad. Sci. USA, 1982, 79, 6385.
42. Oreland, L.; Stenström, A.; d Arai, Y. Biogenic Amines, 1989, 6, 487.
43. Ekblom, J.; Garpenstrand, H.; Damberg, M.; Chen, K.; Shih, J.C.; Oreland, L. Neuroscience Lett., 1998, 258, 101.
44. Takahashi, S.; Tani, N.; Yamane, H. Fol. Psychiatr. et. Neurol. Jap., 1976, 30, 455.
45. Wiberg, Å.; Gottfries, C.G.; Oreland, L. Med. Biol., 1977, 55, 181.
46. Major, L.F.; Murphy, D.L. Br. J. Psychiatr., 1978, 132, 548.
47. von Knorring, L.; Oreland, L. Alcoholism Clin. and Exp. Res., 1996, 20 Suppl., 224A.
48. Cloninger, C.R.; Bohman, M.; Sigvardssson, S. Arch Gen. Psychiat., 1981, 38, 861.
49. Babor, T.F.; Hofman, M.; DelBoca, F.K.; Hesselbrock, V.; Meyer, R.E.; Dolinsky, Z.S.; Rounsaville, B. Arch Gen. Psychiatry, 1992, 49, 599.
50. Langbehn, D.R.; Cadoret, R.J.; Caspres, K.; Troughton, E.P.; Yucuis, R. Drug Alcohol Depend, 2003, 69, 151.
51. von Knorring, A.L.; Bohman, M.; v. Knorring, L.; Oreland, L. Acta Psychiat. Scand., 1985, 72, 51.
52. af Klinteberg, B.; Schalling, D.; Edman, G.; Oreland, L.; Åsberg, M. Neuropsychobiology 1987, 18, 89.
53. Oreland, L. Monoamine Oxidase in neuropsychiatric disorders. In: monoamine oxidase: Basic and Clinical Aspects (Yasuhara H, Parvez SH, Sandler M, Oguchi K, Nagatsu T, Eds). VSP press, Utrecht, The Netherlands, 1993, pp. 219-247.
54. af Klinteberg, B.; Oreland, L.; Hallman, J.; Wirsén, A.; Schalling, D. Neuropsychobiology, 1990, 23, 188.
55. Zuckerman, M. Sensation Seeking. Beyond the Optimal Level of Arousal. Lawrence Erlbaum. Hillsdale, NJ., 1979.
56. Schalling, D. The trait-situation and the physiological correlates of behaviour. In Personality at the Cross-roads (ed. Magnusson D and Endler NS) Lawrence Erlbaum: Hillsdale, NJ, 1977.
57. Oreland, L.; Fowler, C.J.; Schalling, D. Life Sci., 1981, 29, 2511.
58. Fowler, J.S.; Volkow, N.D.; Logan, J.; Pappas, N.; King, P.; MacGregor, R.; Shea, C.; Garza, V.; Gatley, S.J. Life Sci., 1998, 63, 19.
59. Propping, P.; Ray, E.R.; Friedl, W.; Beckman, H. Arch Psychiatr. Nervenkr., 1981, 230, 209.
60. Norman, T.R.; Chamberlain, K.G.; French, M.A.; Burrows, G.D. J. Affective Disord, 1982, 4, 73.
61. Berlin, I.; Anthenelli, R.M. Int. J. Neuropsychopharmacol., 2001, 4, 33.
62. Yu, P.H.; Boulton, A.A. Life Sciences, 1987, 41, 675.
63. Norman, T.R.; Chamberlain, K.G.; French, M.A. Psychiatry Research, 1987, 20, 199.
64. Mendez-Alvarez, E.; Soto-Otero, R.; Sanchez-Sellero, I.; Lopez Rivadulla-Lamas, M. Life Sciences, 1997, 60, 1719.
65. Hauptmann, N.; Shih, J.C. Life Sci., 2001, 68, 1231.
66. Khalil, A.A.; Steyn, S.; Castagnoli, N. Jr. Chem. Res. Toxicol., 2000, 13, 31.
67. Berlin, I.; Said, S.; Spreux-Varoquaux, O.; Olivares, R.; Launay, J.M.; Puech, A.J. Biol. Psychiatry, 1995, 38, 756.
68. Berlin, I.; Spreux-Varoquaux, O.; Launay, J.M. Nicotine Tob. Res., 2000, 2, 243.
69. Fowler, J.S.; Volkow, N.D.; Wang, G.J.; Pappas, N.; Logan, J.; MacGregor, R.; Alexoff, D.; Shea, C.; Schlyer, D.; Wolf, A.P.; Warner, D.; Zezulkova, I.; Cilento, R. Nature, 1996, 379, 733.
70. Fowler, J.S.; Volkow, N.D.; Wang, G.J.; Pappas, N.; Logan, J.; Shea, C.; Alexoff, D.; MacGregor, R.R.; Schlyer, D.J.; Zezulkova, I.; Wolf, A.P. Proc. Natl. Acad. Sci. USA, 1996, 93 14065.
71. Fowler, J.S.; Wang, G.J.; Volkow, N.D.; Franceschi, D.; Logan, J.; Pappas, N.; Shea, C.; MacGregor, R.R.; Garza, V. Nicotine Tob. Res., 1999, 1, 325.
72. Fowler, J.S.; Wang, G.J.; Volkow, N.D.; Franceschi, D.; Logan, J.; Pappas, N.; Shea, C.; MacGregor, R.R.; Garza, V. Am. J. Psychiatry, 2000, 157, 1864.
73. Fowler, J.S., Logan, J.; Wang, G.J.; Volkow, N. NeuroToxicol., 2003, 24, 75.
74. Sullivan, P.F.; Kendler, K.S. Nicotine Tob. Res., 1999, 1(Suppl. 2), 51.
75. Reuter, M.; Netter, P. Neuropsychobiology, 2001, 44, 47.
76. Spielberger, C.D.; Jacobs, G.A. J. Pers. Assess, 1982, 46, 396.
77. Zuckerman, M.; Buchsbaum, M.s.; Murphy, D.L. Psychol. Bull., 1980, 88, 187.
78. Perkins, K.A.; Gerlach, D.; Broge, M.; Grobe, J.E.; Wilson, A. Exp. Clin. Psychopharmacol., 2000, 8, 462.
79. Kopstein, A.N.; Crum, R.M.; Celentano, D.D.; Martin, S.S. Drug Alcohol Depend., 2001, 62, 195.
80. Ravaja, N.; Keltikangas-Jarvinen, K. J. Stud. Alcohol, 2001, 62, 98.
81. von Knorring, L.; Oreland, L. Psychological Med., 1985, 15, 327.
82. von Knorring, L.; Oreland, L.; Winblad, B. Psychiat. Res., 1984, 12, 11.
83. Oreland, L.; Garpenstrand, H.; Damberg, M.; Alm, P.O.; Thorell, L.H.; af Klinteberg, B.; Ekblom, J. Neurobiology, 1999, 7, 191.
84. Ward, P.B.; Catts, S.V.; Norman, T.R.; Burrows, G.D.; McConaghy, N. Acta Psychiatr. Scand., 1987, 75, 86.
85. Wyatt, R.J.; Potkin, S.G.; Murphy, D.L. Am. J. Psychiatry, 1979, 136, 377.
86. Fleissner, A.; Seifert, R.; Schneider, K., Eckert, W.; Fuisting, B. Eur. Arch Psychiatr. Neurol. Sci., 1987, 237, 8.
87. Marcolin, M.A.; Davis, J.M. Schizophrenia Research, 1992, 7, 249.
88. de Leon, J.; Dadvand, M.; Canuso, C.; White, A.O.; Stanilla, J.K.; Simpson, G.M. Am. J. Psychiatry, 1995, 152, 453.
89. Simpson, G.M.; Shih. J.C.; Chen, K.: Flowers, C.; Kumazawa, T.; Spring, B. Neuropsychopharmacology, 1999, 20, 392.
90. Oreland, L.; Damberg, M.; Hallman, J.; Garpenstrand, H. J. Neural. Transm., 2002, 109, 963.
91. Redmond, D.E.; Murphy, D.L.; Baulu, J. Psychosom. Med., 1979, 41, 87.
92. Sostek, A.J.; Miller Sostek, A.; Murphy, D.L.; Bond Martin, E.; Smith Born, W. Life Science, 1981, 28, 2561.
93. Stålenheim, E.G.; von Knorring, L.; Oreland, L. Psychiat. Res., 1997, 6, 79.
94. Garpenstrand, H.; Longato-Stadler, E.; af Klinteberg, B.; Grigorenko, E.; Damberg, M.; Oreland, L.; Hallman, J. Eur. Neuropsychopharmacol., 2002, 12, 135.
95. Whitfield, J.B.; Pang, D.; Bucholz, K.K.; Madden, P.A.; Heath, A.C.; Statham, D.J.; Martin, N.G. Psychol. Med., 2000, 30, 443.
96. Eysenck, M.J.; Eysenck, S.B.G. Manual of the Eysenck personality questionnaire. London, Hodder and Stoughton, 1975.
97. Kirk, K.M.; Whitfield, J.B.; Pang, D.; Heath, A.C.; Martin, N.G. Am. J. Med. Gen., 2001, 105, 700.
98. Anthenelli, R.M.; Tipp, J.; Li, T.K.; Magnes, L.; Schuckit, M.A.; Rice, J.; Daw, W.; Nurnberger, J.I. Jr. Alcohol Clin. Exp. Res., 1998, 22, 598.
99. Farren, C.K.; Clare, A.W.; Tipton, K.F.; Dinan, T.G. J. Psych. Res., 1998, 32, 49.
100. Higley, J.D.; Suomi, S.J.; Linnoila, M. Alcohol Clin. Exp. Res., 1996, 20, 629.
101. Fahlke, C.; Garpenstrand, H.; Oreland, L.; Suomi, S.; Higley, D. Am. J. Psychiat., 2002, 159, 2107.
102. Virkkunen, M.; Linnoila, M. J. Stud. Alc. Suppl., 1993, 11, 163.
103. Parsian, A.; Cloninger, C.R. Psychiatr. Genet., 2001, 11, 89.
104. Demir, B.; Uçar, G.; Ulug, B.; Ulusoy, S.; Seving, I. Batur, S. Alc. and Alc., 2002, 37, 597.
105. Snell, L.D.; Glanz, J.; Tabakoff, B. Alcohol Clin. Exp. Res., 2002, 26, 1105.
106. Sherif, F.; Hallman, J.; Oreland, L. Alcoholism: Clinical and Exp. Res., 1992, 16, 1014.
107. Hallman, J.; v. Knorring, L.; Oreland, L. J. of Studies on Alcohol, 1996, 57, 155.
108. Oreland, L.; Hallman, J. Progr. Brain Res., 1995, 106, 77.
109. Oreland, L.; Wiberg, Å.; Åsberg, M.; Träskman, L.; Sjöstrand, L.; Thorén, P.; Bertilsson, L.; Tybring, G. Psychiat. Res., 1981, 4, 21.
110. Brown, G.L.; Goodwin, F.K.; Ballenger, J.C.; Goyer, P.F.; Major, L.F. Psychiat. Res., 1979, 1, 131.
111. Kruesi, M.J.; Rapoport, J.L.; Hamburger, S.; Hibbs, E.; Potter, W.Z.; Lenane, M.; Brown, G.L. Arch Gen. Psychiatry, 1990, 47, 419.
112. Higley, J.D.; Mehlman, P.T.; Poland, R.E.; Taub, D.M.; Vickers, J.; Suomi, S.J.; Linnoila, M. Biol. Psychiatry, 1996, 40, 1067.
113. af Klintberg, B.; Oreland, L. Personal. Indiv. Diff., 1995, 19, 373.
114. von Knorring, L.; Oreland, L. Alcoholism: Alcoholism: Clinical and Experimental Research, 1996, 20, 224.
115. Hallikainen, T.; Saito, T.; Lachman, H.M.; Volavka, J.; Pohjalainen, T.; Ryynanen, O.P.; Kauhanen, J.; Syvalathi, E.; Hietala, J.; Tiihonen, J. Mol. Psychiatr., 1999, 4, 385.
116. Mantere, T.; Tupala, E.; Hall, H.; Sarkoija, T.; Rasanen, P.; Bergström, K.; Callaway, J.; Tiihonen, J.; Am. J. Psychiatry, 2002, 159, 599.
117. Heinz, A.; Jones, D.W.; Gorey, J.G.; Bennet, A.; Suomi, S.J.; Weinberger, D.R.; Higley, J.D. Mol. Psychiat., 2003, 8, 231.
118. Laine, T.P.J; Ahonen, A.; Räsänen, P.; Tiihonen, J. The Islandic Med. J., 2003, 46, 30.
119. Oreland, L. The activity of human brain and thrombocyte monoamine oxidase (MAO) in relation to various psychiatric disorders. I. MAO Activity in some disease states. In Singer T, von Korff R, Murphy D. (Eds.). Monoamine oxidase; structure, function and altered functions., 1979, Academic Press, New York, 379-387.
120. Oreland, L.; Shaskan, E.G. Trends Pharmacol. Sci., 1983, 4, 339.
121. Williams, T.; Admon, A.; Luscher, B.; Tjian, R. Genes Dev., 1988, 2, 1557.
122. Moser, M.; Imhof, A.; Pscherer, A.; Bauer, R.; Amselgruber, W.; Sinowatz, F.; Hofstadter, F.; Schule, R.; Buettner, R. Development, 1995, 121, 2779.
123. Chazaud, C.; Oulad-Abdelghani, M.; Bouillet, P.; Decimo, D.; Chambon, P.; Dolle, P. Mech. Dev., 1996, 54, 83.
124. Oulad-Abdelghani, M.; Bouillet, P.; Chazaud, C.; Dolle, P.; Chambon, P. Exp. Cell Res., 1996, 225, 338.
125. Zhao, F.; Satoda, M.; Licht, J.D.; Hayashizaki, Y.; Gelb, B.D. J. Biol. Chem., 2001, 276, 40755.
126. Mitchell, P.J.; Timmons, P.M.; Hebert, J.M.; Rigby, P.W.; Tjian, R. Genes Dev., 1991, 5, 105.
127. Williams, T.; Tjian, R. Genes Dev., 1991, 5, 670.
128. Greco, D.; Zellmer, E.; Zhang, Z.; Lewis, E. J. Neurochem., 1995, 65, 510.
129. Bosher, J.M.; Totty, N.F.; Hsuan, J.J.; Williams, T.; Hurst, H.C. Oncogene, 1996, 13, 1701.
130. Roesler, W. J.; Vandenbark, G.R. J. Biol. Chem., 1988, 263, 9063.
131. Bauer, R.; Imhof, A. Nucleic Acids Res., 1994, 22, 1413.
132. Mitchell, P. J.; Wang, C. Cell, 1987, 50, 847.
133. Kawanishi, Y.; Harada, S. J. Hum. Genet., 2000, 45, 24.
134. Moser, M.; Pscherer, A.; Roth, C.; Becker, J.; Mucher, G.; Zerres, K.; Dixkens, C.; Weis, J.; Guay-Woodford, L.; Buettner, R.; Fassler, R. Genes Dev., 1997, 11, 1938.
135. Damberg, M.; Garpenstrand, H.: Berggard, C.; Asberg, M.; Hallman, J.; Oreland, L. Neurosci. Lett., 2000, 291, 204.
136. Damberg, M.; Berggård, C.; Mattila-Evenden, M.; Rylander, G.; Forslund, K.; Garpenstrand, H.; Bergman, H.; Gustavsson, J.P.; Jönsson, E.G. Neuropsychobiology, 2003, 48, 169.
137. Damberg, M.; Garpenstrand, H.; Forslund, K.; Rylander, G.; Oreland, L. Mol. Psychiatry, 2000, 5, 220.
138. Damberg, M.; Garpenstrand, H.; Hallman, J.; Oreland, L. Molecular Psychiatry, 2001, 6, 503.
139. Jönsson, E.; Damberg, M.; Forslund, K., Mattila-Evenden, M.; Rylander, G.; Åsberg, M.; Oreland, L.; Sedvall, G. Neurosci. Lett., 2002, 330, 290.
140. Shimada, M.; Konishi, Y. Neurosci. Res., 1999, 33, 275.
141. Gen Bank acc. no. U13956.
142. Boularand, S.; Darmon, M.C.; Ravassard, P.; Mallet, J. J. Biol. Chem., 1995, 270, 3757.
143. Kobayashi, K.; Kurosawa, Y.; Fujita, K.; Nagatsu, T. Nucleic Acids Res., 1989, 17, 1089.
144. McMahon, A.; Kvetnansky, R.; Fukuhara, K.; Weise, V.K.; Kopin, I.J.; Sabban, E.L. J. Neurochem., 1992, 58, 2124.
145. Hahn, S.L.; Hahn, M.; Kang, U.J.; Joh, T.H. J. Neurochem., 1993, 60, 1058.
146. Du, Y.L.; Wilcox, B.D.; Teitler, M.; Jeffrey, J.J. Mol. Pharmacol., 1994, 45, 1125.
147. Baskin, F.; Li, Y.P.; Hersh, L.B.; Davis, R.M.; Rosenberg, R.N. Neuroscience, 1997, 76, 821.
148. Bradley, C.C.; Blakely, R.D. J. Neurochem., 1997, 69, 1356.
149. Healy, D.P.; O'Rourke, D.A. Clin. Exp. Hypertens., 1997, 19, 1.
150. Quirin-Stricker, C.; Mauvais, C.; Schmitt, M. Brain Res. Mol. Brain Res., 1997, 49, 165.
151. Kim, H.S.; Hong, S.J.; LeDoux, M.S.; Kim, K.S. J. Neurochem., 2001, 76, 280.
152. Takeuchi, S.; Waragi, M.; Roth, C.; Kanazawa, I.; Buettner, R.; Mouradian, M.M.; Okazawa, H. Brain Res. Mol. Brain Res., 1999, 74, 208.
153. Damberg, M.; Eller, M.; Tönissaar, M.; Oreland, L.; Harro, J. Neurosci. Lett., 2001, 313, 102.
154. Gustavsson, J.P.; Bergman, H.; Edman, G.; Ekselius, L.; von Knorring, L.; Linder, J. Acta Psychiatr. Scand., 2000, 102, 217.
155. Gustavsson, J.P.; Jönsson, E.G.; Linder, J.; Weinryb, R.M. Pers. Individ. Diff., 2003, 35, 6.
156. Cloninger, C.R.; Przybeck, T.R.; Svrakic, D.M.; Wetzel, R.D. The temperament and Character Inventory (TCI): A guide to its development and use. StLouis:Center for Psychobiology of Personality, 1994.
157. Bergman, H. NEO-PI-R. Paul Costa & Robert R McCrae. Manual. Svensk version. Stockholm: Psykologiförlaget AB, 2003.
158. Laakso, A.; Wallius, E.; Kajander, J.; Bergman, J.; Eskola, O.; Solin, O.; Ilonen, T.; Salokangas, R.K.R.; Syvälathi, E.; Hietala, J. Am. J. Psychiatry, 2003, 160, 904.
159. Ebstein, R.P.; Bejamin, J.; Belmaker, R.H. Eur. J. Pharmacol, 2000, 410, 205.
160. Reif, A.; Lesch, K.P. Behav. Brain Res., 2003, 139, 1.
161. Kuikka, J.T.; Tammela, L.I.; Karhunen, L.J.; Rissanen, A.; Bergström, K.A.; Naukkarinen, H.; Lappalainen, R.; Repo-Tiihonen, E.; Tiihonen, J.; Uusitupa, M. Psychopharmacology, 2001, 155, 310.
162. Tammela, L.I.; Rissanen, A.; Kuikka, J.T; Karhunen, L.J.; Bergström, K.A.; Repo-Tiihonen, E.; Naukkarinen, H.; Vanninen, E.; Tiihonen, J.; Uusitupa, M. Psychopharmacology, 2003, 170, 89.
163. Murphy, D.L; Qian, L.; Engel, S.; Wichems, C.; Andrews, A.; Lesch, K.P.; Uhl, G.; Brain Res. Bull., 2001, 26, 487.
164. Prince, J.; Shia, J.; Båve, U.; Annerén, G.; Oreland, L. J. Neural. Transm., 1994, 8, 171.